Polymorphisms in the Caspase7 gene and the risk of lung cancer

Lung Cancer

Volumn 65, Issue 1, 2009, Pages 19-24

  Lee, Won Kee ^a   Kim, Jong Sik ^a   Kang, Hyo Gyoung ^a   Cha, Sung Ick ^b   Kim, Dong Sun ^a   Hyun, Dae Sung ^c   Kam, Sin ^a   Kim, Chang Ho ^b   Jung, Tae Hoon ^b   Park, Jae Yong ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Daegu University   (South Korea)

Author keywords

Apoptosis; Case control study; Caspase7; Lung cancer; Polymorphism; Susceptibility

Indexed keywords

CASPASE 7;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CASPASE 7; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67349094067     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.10.022     Document Type: Article

References (30)

1. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3 (2002) 461-469
2. Shields P.G., and Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18 (2000) 2309-2315
3. Kiyohara C., Otsu A., Shirakawa T., et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37 (2002) 241-256
4. Neumann A.S., Sturgis E.M., and Wei Q. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42 (2005) 65-92
5. Zhang X., Miao X., Sun T., et al. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42 (2005) 479-484
6. Frank B., Bermejo J.L., Hemminki K., et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 97 (2005) 1012-1013
7. Park J.Y., Park J.M., Jang J.S., et al. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet 15 (2006) 1963-1971
8. Jacobson M.D., Weil M., and Raff M.C. Programmed cell death in animal development. Cell 88 (1997) 347-354
9. Ameisen J.C. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ 9 (2002) 367-393
10. Thompson C.B. Apoptosis is the pathogenesis and treatment of disease. Science 67 (1995) 1456-1462
11. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 11 (2001) 342-348
12. Shivapurkar N., Reddy J., Chaudhary P.M., and Gazdar A.F. Apoptosis and lung cancer: a review. J Cell Biochem 88 (2003) 885-898
13. Degterev A., Boyce M., and Yuan J. A decade of caspases. Oncogene 22 (2003) 8543-8567
14. Fuentes-Prior P., and Salvensen G.S. The protein structures that shape caspases activity, specificity, activation and inhibition. Biochem J 384 (2004) 201-232
15. Jang J.S., Kim K.M., Kang K.H., et al. Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60 (2008) 31-39
16. Parks S.B., Popovich B.W., and Press R.D. Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes. Am J Clin Pathol 115 (2001) 439-447
17. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
18. Stephens M., Smith M.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
19. Schaid D.J., Rowland C.M., Tines D.E., et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
20. Imyanitov E., Hanson K., and Zhivotovsky B. Polymorphic variations in apoptotic genes and cancer predisposition. Cell Death Diff 12 (2005) 1004-1007
21. Rebbeck T.R., Spitz M., and Wu X. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5 (2004) 589-597
22. Sunyaev S., Ramensky V., Koch I., Lathe III W., et al. Prediction of deleterious human alleles. Hum Mol Genet 10 (2001) 591-597
23. Zhu Y., Spitz M.R., Amos C.I., et al. An evolutionary perspective on single-nucleotide polymorphisms screening in molecular cancer epidemiology. Cancer Res 64 (2004) 2251-2257
24. Fernandes-Alnemri T., Takahashi A., Armstrong R., et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55 (1995) 6045-6052
25. Garcia-Lozano J.R., Torres B., Fernandez O., et al. Caspase 7 influences susceptibility to rheumatoid arthritis. Rheumatology 46 (2007) 1243-1247
26. Judson R., Stephens J.C., and Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics 1 (2000) 15-26
27. Judson R., and Stephens J.C. Notes from the SNP vs. haplotype front. Pharmacogenomics 2 (2001) 7-10
28. Bader J.S. The relative power of SNPs and haplotypes as genetic markers for association tests. Pharmaocogenomics 2 (2001) 11-24
29. Hoh J., and Hodge S. A measure of phase ambiguity in pairs of SNPs in the presence of linkage disequilibrium. Hum Hered 50 (2000) 359-364
30. Xu C.F., Lewis K., Cantone K.L., et al. Effectiveness of computational methods in haplotype estimation. Hum Genet 110 (2002) 148-156